MENU

These small cap ASX shares have pushed higher on Wednesday

It has been a volatile day for the ASX and in afternoon trade the market has tumbled slightly into the red.

But that hasn’t stopped three shares at the small end of the market from pushing higher today. Here’s why they are on the rise:

The Fluence Corporation Ltd (ASX: FLC) share price is up 5% to 40.5 cents. This morning the provider of decentralised water, wastewater treatment, and reuse solutions announced its first waste-to-energy harvesting project in Argentina. According to the release, the company will design and build a €1.7 waste-to-energy system for prominent beef processor ArreBeef Energia. The system will be designed and built using anaerobic digestion technology which has been developed by Fluence to produce biogas, as well as electrical and thermal energy. The system is expected to be installed and operational onsite by November 2019.

The Opthea Ltd (ASX: OPT) share price has jumped 7% to 63 cents after the clinical-stage biopharmaceutical company developing novel biologic therapies to treat back-of-the-eye diseases announced that it has received a $12 million research and development tax credit from the Australian Taxation Office. CEO and managing director, Dr Megan Baldwin, commented: “This R&D tax incentive credit of $12 million increases the company’s cash balances to over $36 million and will contribute to the execution and delivery of outcomes from our clinical trials of OPT-302 in both wet AMD and DME.”

The ResApp Health Ltd (ASX: RAP) share price has rebounded 20% higher to 12 cents. On Tuesday the digital health company’s shares more than halved in value after the release of disappointing results from its SMARTCOUGH C-2 study. The results of the study, particularly for pneumonia and bronchiolitis, were extremely underwhelming. Based on the results, I suspect that there are concerns now that its ResAppDx smartphone application has no future in diagnosing pneumonia and bronchiolitis.

Missed these gains? Then don't miss out on these mid cap shares tipped for big things.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Atlassian.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!